Published May 16, 1983 | Version v1
Patent Open

Imaging tumors with radiolabelled monoclonal antibodies

Description

Using a metallic radionuclide, either directly bound to a monoclonal antibody, or to a chelating agent (such as di-ethylenetriamine-pentaacetic acid (DTPA)) conjugated to the antibody, a tumor can be traced rapidly and with high specificity. The labelled antibody is injected into the host. In some cases, a localization of distant metastases is possible, giving an indication of tumor spreading. Detection occurs by photoscanning. (Auth.)

Availability note (English)

MF available from INIS under the Report Number.

Files

14806531.pdf

Files (972.4 kB)

Name Size Download all
md5:12507dab241ee1c8205795c4d6ceaa4e
972.4 kB Preview Download

Additional details

Additional titles

Original title (Dutch)
In beeld brengen van tumor met radioactief gemerkte monoclonale antilichamen

Publishing Information

Imprint Pagination
29 p.
IPC:
Int. Cl. A61k49/02; G01n33/56.
IPC
Int. Cl. A61k49/02; G01n33/56.
Patent number
NL patent document 8204108/A/

INIS

Country of Publication
Netherlands
Country of Input or Organization
Netherlands
INIS RN
14806531
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
LABELLING; METASTASES; MONOCLONAL ANTIBODIES; NEOPLASMS; RADIOISOTOPE SCANNING; TRACER TECHNIQUES; TUMOR CELLS
Descriptors DEC
ANIMAL CELLS; ANTIBODIES; COUNTING TECHNIQUES; DISEASES; ISOTOPE APPLICATIONS

Optional Information

Notes
4 figs.
Secondary number(s)
US priority 315286.